Article detail · 2026
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Group
CLINICAL & TRANSLATIONAL ONCOLOGY
YÖKSİS
OpenAlex
SJR Q2
JCR Q3
Citations 0
Percentile 10.9%
FWCI 0.0
- Year
- 2026
- ISSN
1699-048X- Type
- article
Data source split
- YÖKSİS YÖKSİS article record
- OpenAlex OpenAlex enrichment (abstract, citations, topics)
Abstract
No OpenAlex abstract is available for this article yet.
Topics
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Chronic Myeloid Leukemia Treatments
Primary topic Lung Cancer Treatments and Mutations